BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8962174)

  • 1. Immunomodulation by HLA class I-derived peptides.
    Krensky AM; Clayberger C
    Transplant Proc; 1996 Dec; 28(6):3026-8. PubMed ID: 8962174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells in autoimmunity and allograft rejection.
    Krensky AM
    Kidney Int Suppl; 1994 Jan; 44():S50-6. PubMed ID: 8127034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic tolerance: tailored antigen.
    Krensky AM; Clayberger C
    Transplant Proc; 1996 Aug; 28(4):2075-7. PubMed ID: 8769160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
    Butterfield LH; Koh A; Meng W; Vollmer CM; Ribas A; Dissette V; Lee E; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 1999 Jul; 59(13):3134-42. PubMed ID: 10397256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of peptide-specific T cells to stimulation with polystyrene beads carrying HLA class I molecules loaded with single peptides.
    Chersi A; Galati R; Accapezzato D; Francavilla V; Barnaba V; Butler RH; Tanigaki N
    J Immunol Methods; 2004 Aug; 291(1-2):79-91. PubMed ID: 15345307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
    Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
    Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NK cells and NKT cells].
    Satoh T; Arase H
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():159-65. PubMed ID: 15861651
    [No Abstract]   [Full Text] [Related]  

  • 11. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-derived peptides as novel immunosuppressives.
    Krensky AM
    Pediatr Res; 1995 Sep; 38(3):275-9. PubMed ID: 7494646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pictures of MHC restriction.
    Parham P
    Nature; 1996 Nov; 384(6605):109-10. PubMed ID: 8906779
    [No Abstract]   [Full Text] [Related]  

  • 15. Play it in E or G: utilization of HLA-E and -G in xenotransplantation.
    Crew MD
    Xenotransplantation; 2007 May; 14(3):198-207. PubMed ID: 17489859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
    Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P
    Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules.
    Di Modugno F; Mammi C; Rosanò L; Rubiu O; Nisticò P; Chersi A
    J Immunother; 1997 Nov; 20(6):431-6. PubMed ID: 9409448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
    Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
    Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.